Viewing StudyNCT00117104



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00117104
Status: COMPLETED
Last Update Posted: 2009-10-16
First Post: 2005-06-30

Brief Title: Evaluating Aranesp in Subjects With End Stage Renal Disease onChronic Hemodialysis
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
End Stage Renal Disease
Keywords:
Name View
Dosing Amgen View
End Stage Renal Disease ESRD View
Kidney Disease Dialysis View
Aranesp rHuEPO View
Anemia Hemoglobin View